Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 08 2022
Historique:
received: 22 09 2021
accepted: 23 02 2022
pubmed: 18 3 2022
medline: 29 6 2022
entrez: 17 3 2022
Statut: ppublish

Résumé

Phylogenetic analyses of 2 or more countries allow to detect differences in transmission dynamics of local HIV-1 epidemics beyond differences in demographic characteristics. A maximum-likelihood phylogenetic tree was built using pol -sequences of the Swiss HIV Cohort Study (SHCS) and the Austrian HIV Cohort Study (AHIVCOS), with international background sequences. Three types of phylogenetic cherries (clusters of size 2) were analyzed further: (1) domestic cherries; (2) international cherries; and (3) SHCS/AHIVCOS-cherries. Transmission group and ethnicities observed within the cherries were compared with the respective distribution expected from a random distribution of patients on the phylogeny. The demographic characteristics of the AHIVCOS (included patients: 3'141) and the SHCS (included patients: 12'902) are very similar. In the AHIVCOS, 36.5% of the patients were in domestic cherries, 8.3% in international cherries, and 7.0% in SHCS/AHIVCOS cherries. Similarly, in the SHCS, 43.0% of the patients were in domestic cherries, 8.2% in international cherries, and 1.7% in SHCS/AHIVCOS cherries. Although international cherries in the SHCS were dominated by heterosexuals with men who have sex with men being underrepresented, the opposite was the case for the AHIVCOS. In both cohorts, cherries with one patient belonging to the transmission group intravenous drug user and the other one non-intravenous drug user were underrepresented. In both cohorts, international HIV transmission plays a major role in the local epidemics, mostly driven by men who have sex with men in the AHIVOS, and by heterosexuals in the SHCS, highlighting the importance of international collaborations to understand global HIV transmission links on the way to eliminate HIV.

Identifiants

pubmed: 35298446
doi: 10.1097/QAI.0000000000002949
pii: 00126334-202208010-00007
pmc: PMC9394492
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4-e12

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393:2428–2438.
Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171–181.
Bavinton BR, Pinto AN, Phanuphak N, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5:e438–e447.
UNAIDS. UNAIDS: global commitments, local action: after 40 years of AIDS, charting a course to end the pandemic [Internet]. Available at: https://www.unaids.org/sites/default/files/media_asset/global-commitments-local-action_en.pdf . Accessed April 15, 2022.
von Wyl V, Kouyos RD, Yerly S, et al. The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis. 2011;204:1095–1103.
Kouyos RD, von Wyl V, Yerly S, et al. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis. 2010;201:1488–1497.
Hughes GJ, Fearnhill E, Dunn D, et al. Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog. 2009;5:e1000590.
Lewis F, Hughes GJ, Rambaut A, et al. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med. 2008;5:e50.
van de Vijver DAMC, Boucher CAB. Insights on transmission of HIV from phylogenetic analysis to locally optimize HIV prevention strategies. Curr Opin HIV AIDS. 2018;13:95–101.
Bezemer D, Cori A, Ratmann O, et al. Dispersion of the HIV-1 epidemic in men who have sex with men in The Netherlands: a combined mathematical model and phylogenetic analysis. PLoS Med. 2015;12:e1001898.
Castor D, Low A, Evering T, et al. Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City. J Acquir Immune Defic Syndr. 2012;61:1–8.
Junqueira DM, Sibisi Z, Wilkinson E, et al. Factors influencing HIV-1 phylogenetic clustering. Curr Opin HIV AIDS. 2019;14:161–172.
Hassan AS, Pybus OG, Sanders EJ, et al. Defining HIV-1 transmission clusters based on sequence data. AIDS. 2017;31:1211–1222.
Zahlen zu HIV/Aids [Internet]. Aids-Hilfe Schweiz. 2020. Available at: https://www.aids.ch/de/haeufigste-fragen/hiv-aids/zahlen/ . Accessed April 15, 2022.
“VIRUSEPIDEMIOLOGISCHE INFORMATION” NR. 03/20 [Internet]. 2021. Available at: https://www.virologie.meduniwien.ac.at/fileadmin/virologie/files/Epidemiologie/2020/0320.pdf . Accessed April 15, 2022.
Duran Ramirez JJ, Ballouz T, Nguyen H, et al. Increasing frequency and transmission of HIV-1 non-B subtypes among men who have sex with men in the Swiss HIV cohort study. J Infect Dis. 2022;225:306–316.
Marzel A, Shilaih M, Yang WL, et al. HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV cohort study. Clin Infect Dis. 2016;62:115–122.
Turk T, Bachmann N, Kadelka C, et al. Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. eLife. 2017;6:6.
Marzel A, Kusejko K, Weber R, et al. The cumulative impact of harm reduction on the Swiss HIV epidemic: cohort study, mathematical model, and phylogenetic analysis. Open Forum Infect Dis. 2018;5:ofy078.
Paraskevis D, Beloukas A, Stasinos K, et al. HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors. BMC Med. 2019;17:4.
Hoenigl M, Chaillon A, Kessler HH, et al. Characterization of HIV transmission in south-east Austria. PLoS One. 2016;11:e0151478.
Swiss HIV Cohort Study; Schoeni-Affolter F, Ledergerber B, Rickenbach M, et al. Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol. 2010;39:1179–1189.
Scherrer AU, Traytel A, Braun DL, et al. Cohort profile update: the Swiss HIV cohort study (SHCS). Int J Epidemiol. 2022;51:33–34j.
37th report of the Austrian HIV cohort study [Internet]. AGES—Österreichische Agentur für Gesundheit und Ernährungssicherheit. 2020. Available at: https://www.ages.at/service/service-oeffentliche-gesundheit/berichte-folder-und-formulare/37th-report-of-the-austrian-hiv-cohort-study/ . Accessed April 15, 2022.
About SHCS—Swiss HIV cohort study [Internet]. 2022. Available at: https://www.shcs.ch/157-about-shcs . Accessed April 15, 2022.
Berichte & Folder der Öffentlichen Gesundheit [Internet]. AGES. 2022. Available at: https://www.ages.at/mensch/krankheit/oeffentliche-gesundheit-services/berichte-folder . Accessed April 15, 2022.
Struck D, Lawyer G, Ternes AM, et al. COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification. Nucleic Acids Res. 2014;42:e144.
Johnson VA, Calvez V, Gunthard HF, et al. Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med. 2013;21:6–14.
Bennett DE, Camacho RJ, Otelea D, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4:e4724.
Lartillot N, Philippe H. A bayesian mixture model for across-site heterogeneities in the amino-acid replacement process. Mol Biol Evol. 2004;21:1095–1109.
Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol. 2009;26:1641–1650.
Price MN, Dehal PS, Arkin AP. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5:e9490.
Bachmann N, Turk T, Kadelka C, et al. Parent-offspring regression to estimate the heritability of an HIV-1 trait in a realistic setup. Retrovirology. 2017;14:33.
Paradis E, Claude J, Strimmer K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics. 2004;20:289–290.
Brenner B, Wainberg MA, Roger M. Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions. AIDS. 2013;27:1045–1057.
Ragonnet-Cronin ML, Shilaih M, Günthard HF, et al. A direct comparison of two densely sampled HIV epidemics: the UK and Switzerland. Sci Rep. 2016;6:32251.
Ragonnet-Cronin M, Hodcroft E, Hué S, et al. Automated analysis of phylogenetic clusters. BMC Bioinformatics. 2013;14:317.
Kusejko K, Kadelka C, Marzel A, et al. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study. Virus Evol. 2018;4:vey024.
DescTool, R package [Internet]. 2021. Available at: https://cran.r-project.org/web/packages/DescTools/DescTools.pdf . Accessed April 15, 2022.
Camlin CS, Ssemmondo E, Chamie G, et al. Men “missing” from population-based HIV testing: insights from qualitative research. AIDS Care. 2016;28(suppl 3):67–73.
Rosinska M, Pantazis N, Janiec J, et al. Potential adjustment methodology for missing data and reporting delay in the HIV Surveillance System, European Union/European Economic Area. Eurosurveillance. 2018;23:1700359.
European Centre for Disease Prevention and Control. HIV Estimates Accuracy Tool [Internet]. Stockholm, Sweden: ECDC; 2018. Available at: https://ecdc.europa.eu/en/publications-data/hiv-estimates-accuracy-tool . Accessed April 15, 2022.
Kusejko K, Bachmann N, Chaudron SE, et al. A systematic phylogenetic approach to study the interaction of HIV-1 with coinfections, noncommunicable diseases, and opportunistic Diseases. J Infect Dis. 2019;220:244–253.

Auteurs

Katharina Kusejko (K)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Nadine Tschumi (N)

Department of Medicine, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Department of Clinical Research, University of Basel, Basel, Switzerland.

Sandra E Chaudron (SE)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Huyen Nguyen (H)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Manuel Battegay (M)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Enos Bernasconi (E)

Division of Infectious Diseases, Regional Hospital Lugano, University of Geneva and University of Southern Switzerland, Lugano, Switzerland.

Jürg Böni (J)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Michael Huber (M)

Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Alexandra Calmy (A)

Laboratory of Virology and Division of Infectious Diseases, Geneva University Hospital, University of Geneva, Geneva, Switzerland.

Matthias Cavassini (M)

Division of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.

Alexander Egle (A)

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

Katharina Grabmeier-Pfistershammer (K)

Department of Dermatology, Medical University Vienna, Vienna, Austria.

Bernhard Haas (B)

Institute of Hospital Hygiene and Microbiology, Styrian Hospital Corporation, The Styrian Healthcare Company, Graz, Austria.

Hans Hirsch (H)

Molecular Virology, Department of Biomedicine-Petersplatz, University of Basel, Basel, Switzerland.

Thomas Klimkait (T)

Molecular Virology, Department of Biomedicine-Petersplatz, University of Basel, Basel, Switzerland.

Angela Öllinger (A)

Department of Dermatology, Kepler University Hospital, Linz, Austria.

Matthieu Perreau (M)

Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Alban Ramette (A)

Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.

Baharak Babouee Flury (BB)

Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Division of Infectious Diseases, Cantonal Hospital St Gallen, St. Gallen, Switzerland; and.

Mario Sarcletti (M)

Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.

Alexandra Scherrer (A)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.

Patrick Schmid (P)

Division of Infectious Diseases, Cantonal Hospital St Gallen, St. Gallen, Switzerland; and.

Sabine Yerly (S)

Laboratory of Virology and Division of Infectious Diseases, Geneva University Hospital, University of Geneva, Geneva, Switzerland.

Robert Zangerle (R)

Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria.

Huldrych F Günthard (HF)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Roger D Kouyos (RD)

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Institute of Medical Virology, University of Zurich, Zurich, Switzerland.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH